Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |